The Limited Times

Now you can see non-English news...

Corona virus in Germany: seven

2022-01-27T03:39:53.856Z


The Robert Koch Institute registered 188 more deaths related to the corona virus within 24 hours. The number of new infections increases by 203,136 - and the seven-day incidence to 1017.4.


Enlarge image

Preparations for corona tests (archive image)

Photo: Michael Bihlmayer / imago images/Bihlmayerfotografie

These are the next highs: The number of

new corona infections in Germany has increased by

203,136

within 24 hours

.

That is 69,600 more cases than on Thursday a week ago, when 133,536 new infections were reported.

This is based on figures from the Robert Koch Institute (RKI), based on information from the health authorities.

Accordingly, the

seven-day incidence

has also risen to a maximum value of

1017.4

.

The day before, the value was still 940.6.

Within 24 hours,

188 other people have also

died

in connection with the virus

.

The number of corona deaths in Germany thus increases to a total of 117,314.

It was exactly two years ago this Thursday that the first confirmed corona infection was reported in Germany: an employee of the auto supplier Webasto in Stockdorf near Munich was affected.

Moderna starts clinical trial of Omicron vaccine

Meanwhile, the manufacturer Moderna has started its first clinical study to investigate a corona vaccine specially tailored to the omicron variant.

A total of 600 volunteers – some with two or three injections – would take part at 24 locations in the United States, Moderna announced on Wednesday (local time).

The resistance of the antibodies with the normal booster vaccination is optimistic, said Moderna boss Stéphane Bancel.

"Nevertheless, given the long-term threat of the so-called immune escape from Omicron, we continue to advance our Omicron-specific vaccine candidate."

Recently, Biontech and Pfizer also announced the testing of their vaccine candidate against Omikron.

Safety, tolerability and effectiveness are to be checked, as the two companies announced on Tuesday.

The study will include up to 1,420 test subjects, who will be divided into three groups.

The specialist magazine "New England Journal of Medicine" published a study on the effectiveness of the previously approved booster from Moderna against the omicron variant.

According to this, the antibody level against the highly contagious mutation of the coronavirus is 20 times higher one month after the third injection than after the second - but it decreases significantly in the months that follow.

Health Minister Karl Lauterbach tweeted: “The study shows that the Moderna Booster vaccine massively reduces the risk of infection with Omicron.

This is exactly the booster vaccination that we are currently offering in Germany alongside Biontech.«

aar/dpa

Source: spiegel

All tech articles on 2022-01-27

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.